Title: Alterations in Serum Lipid Profile & Lipid Peroxidation Status in Female Breast Tumour Patients
Authors: Dr Sanghamitra Bhoi, Dr Jyotindra Kumar Sahu, Dr Pramila Kumari Mishra, Dr Manmath Kumar Mandal
DOI: https://dx.doi.org/10.18535/jmscr/v5i7.93
Abstract
Breast Carcinoma is the most common cause of death in middle aged women in western countries. In India it is the second most common carcinoma in female next to cervical carcinoma. Our aim was to evaluate the relationship of lipid profile and Lipid peroxidation status with breast tumour. These findings suggest that obesity is not an important risk factor in development breast tumour. Early menarche, late menopause and low parity are definite risk factors. Dyslipidemia is definitely associated with breast tumour whether it is a cause or effect of tumour it is not exactly known. There is definite increase in ROS production oxidative stress is more in case of breast tumour patients both in benign and malignant group.
Keywords: Lipid profile, Malondialdehyde & breast tumour.
References
1. Ramzi .S .Cortan, Vinay kumar ,Stanley L. Robbins , Neoplasia .In Robbins Pathologic basis of diseases . Etdby Schoen F.J . 8thEdn . 2009 .Prism book Pvt . Ltd . 261-295 .
2. Richard Sainsbury,The Breast .In Baily Love`s short practice of surgery ,revised by Norman S. Willium,Christopher J.K Bulstrode,P.Ronon, O.Connel. 25th Edn.-2008 :827.
3. Park K. Epidemiology of chronic non communicable diseases and conditions In: Park’s textbook of preventive and social medicine. 20th ed. Park K. Jabalpur: M/s BanarasidasBhanot; 2009. p. 333-337.
4. ICMR Bulletin, Estrogen and breast cancer Feb 2003,vol 33(2): 13-16.
5. Goedegebuure P.S , Eberlein T .J , Tumour Biology and tumour Markers .In Sabiston text book of Surgery .Etd. by Townsend M.C .,Beauchamp R.D . Evers B.M ,Mattox L.K , 17 * Edn. 2008, Harcourt Asia Pvt. Ltd.:485.
6. Armstrong B, Doll R ,Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices.Int J cancer 1975,15,617-621.
7. Jain D , Ray A , Bahadur A.K , Chaturbedi K.U , Sood R , Sharma S ,NaikS.L.O.SharmaB.K..Status of epidermal growth factor receptors family in hormone dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins .Indian journal of clinical Biochemistry ,2001,16(1):42-51.
8. Marnett LJ. Oxyradicalsand DNA damage .Carcinogenesis 2000 ;21:361-371.
9. Guyton K.Z .Kensler T.W . oxidative damage in carcinogenesis .British Medical Bulletin 1993 ; 49:523-544.
10. Mehta G. Kothari , S .Singh in developing population ;A nutrition caveat. Indian journal of clinical Biochemistry ,2001;16(1):65-71.
11. Kumar V, Abbas AK, Fausto N, Mitchell R. Robbins basic pathology.The breast tumours . 8th edn. Philadelphia: Saunders Elsevier; 2009. p.1068-1069.
12. Ma, H., Bernstein, L., Pike, MC., Ursin, G.,Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8:R43.
13. Alan Potter J Katherine Gallahen A. Flow cytometric of the cell cycle ,phase specificity of DNA damage induced by radiation, Hydrogen peroxide and Doxorubicin and carcinogenesis, 2003, 24(2) 235-241.
14. Fletcher M J. Determination of serum Triglyceride. Clin Chem Acta. 1968;22:293
15. Zlatkis A, Zak B, Boyle J. Estimation of serum HDL-cholesterol. Lab Clin Med 1953:41:486
16. Friedwald W T, Levy R I, Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative centrifuse. Clin Chem 1972:18:499-502.
17. Guyton K.Z .Kensler T.W . oxidative damage in carcinogenesis .British Medical Bulletin 1993 ; 49:523-544.
18. Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004;22:2328–35.
19. Croce CM (January 2008). "Oncogenes and cancer". The New England journa medicine 358(5) : 50211. doi : 10.1056 / NEJ Mra 072367. PMID 18234754.
20. Ross, RK., Paganini-Hill, A., Wan, PC., Mike, PC.,Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J Natl Cancer Inst 2000. 92:328-32
21. Chan, MF., Dowsett, M., Folkerd, E., et alUsual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study Cancer Epidemiol Biomarkers Prev 2007. 16:900-5
22. Varley H. Determination of Total, free and easter cholesterol, using reaction with ferric chloride and sulphuric acid. In: Varley H. Practical Clinical Biochemistry. 4th ed. CBS publisher and distributors: Asia Printograph, 1988:309-326
23. Garrow J .S, Webster J . Qutelet s index as a measure of fatness. International journal of obesity .1985 ;9 147-153.
24. Stephen .N. Bunt J.C .,Salbe .A .D, Fuhanasi J, Matsuzawa. Y and Tattaranni P.A . Plasma adiponectin concentration and its relationship with obesity and carcinoma .Journal of clinical endocrinology and metabolism.,2006 ,87: 4652-4656.
25. Yager JD; Davidson NE (2006). "Estrogen carcinogenesis in breast cancer". New Engl J Med 354(3): 270– 82
26. Mayes P.A ,Lipid transport and storage.Etd by Murray R.K. ,Granner D.K, Mayes P.A ,Rodwell V.W .28 th Edn .2009, Appelton & Lange Publn: 268-272.
27. D.M .Vasudevan, Sreekumari S ,Kannan Vaidyanathan ;Cholesterol and Lipoprotein ; In Text book of Biochemistry ,6th Edn P:144-149
28. Bani I.A., Williams, C.M., Boulter P.S., Dickerson J.W.T.,(1986).Plasma lipids and prolactin in patients with breast cancer. Br. J. Cancer, 54:439-446.
29. Leena Hilakivi-Clarke , Estrogens, BRCA 1 ,BRCA 2 & Breast cancer . Cancer Research 2000 ; 60 4993-5001 .
30. National heart ,lung and blood institute, clinical guidelines on identification, evaluation and treatment of overweight and obesity in adults NIH publication no.98-4083.
31. Lahmann, PH., Friedenreich, C., Schuit, AJ., et alPhysical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol Biomarkers Prev 2007. 16:36-42
32. Dong, J. Y. and Qin, L. Q..,Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies Breast Cancer Res Treat 2011. 125(2):315-23
33. “History of cancer ‘ American cancer society .2002-3-05.Retrieved 2006-10-09.
34. Satoh K (1978). Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin ChimActa, 90(1): 37-43.
35. Tanner, J.M. Trend towards earlier menarche in London, Oslo, Copenhagen, the Netherlands and Hungary. Nature 1973; 243; 5402; 95-6.
36. Andrieu N, Prevost T, Rohan TE, et al. Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol 2000;29:214–23.
37. Tamimi, RM., Byrne, C., Colditz, GA., Hankinson, SE.,Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst 2007. 99:1178-87.
38. Layde, PM., Webster, LA., Baughman, Al., Wingo, PA., et al; The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 1989; 42:963-73
